The QualityStocks Daily Newsletter for Friday, Sept. 10th 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


Wise Penny Stocks (MXMI)


Nebula Stocks (CARN)


Stock Traders Chat (GVDI)

The QualityStocks Daily

FNDS3000 Corp. (FDTC)

Today we are highlighting FNDS3000 Corp. (FDTC), here at the QualityStocks Daily Newsletter.

FNDS3000 Corp is a public financial transaction processing company that trades on the OTCBB. The Company provides various programs and solutions to financial institutions, businesses and individuals on a global basis. Directly or through their partner program, they provide these solutions to more than 50,000 individuals and businesses. FNDS3000 Corp. has their headquarters in Jacksonville, Florida.

The Company's solutions include financial transaction processing solutions that consist of software and hardware specifically designed for the debit card industry. Their solutions also include direct deposit solutions for businesses where a large percentage of their employees are unbanked, as well as ATM/Debit and Prepaid Debit cards.

With operations in South Africa, FNDS3000 Corp engages in executing a series of international growth initiatives designed to position the Company as a major player in the world's fastest growing payment card segment: prepaid cards. With 40 percent of the adult population in South Africa currently unbanked or underbanked, FNDS3000's initial focus has concentrated on offering tailored prepaid card programs and services to business customers in this developing prepaid market.

This includes network branded and closed loop programs that support employee payroll, insurance, medical aid, gift cards, prepaid cellular charges and small-scale international transfer of funds. The Company provides these programs and services through a proven, proprietary U.S. processing platform designed for international and cross border capability.

On September 8, 2010, FNDS3000 Corp. formally commented on positive emerging trends the Company is seeing in the volume of cash loaded onto their prepaid payment processing system by their customers and in the number of cards being issued and activated on a subsequent quarterly basis.

The Company has remained intently focused on building and servicing a growing customer base of South African companies for which FNDS3000 actively manages prepaid payroll card and prepaid microfinance card programs on their proprietary processing platform.
"FNDS3000 has continued to enjoy marked growth in both the number of prepaid cards issued and activated, and the volume of Rands loaded to those cards," said Robert Klein, FNDS3000's President and Country CEO-South Africa.

FNDS3000 Corp. (FDTC) closed Friday’s trading session at $0.09, for no change, on 5,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 3,218 with a 52-week low/high of $0.04/$0.50.

China Shuangji Cement, Ltd. (CSGJ)

Momentum Traders, The Street, and SmallCap Voice reported earlier on China Shuangji Cement, Ltd. (CSGJ), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, China Shuangji Cement, Ltd., through their affiliates and controlled entities, is a leading producer of high-quality Portland cement in Shandong and Hainan Provinces, China. Contractors for the construction of buildings, roads, and other infrastructure projects primarily purchase the Company's processed cement products. China Shuangji Cement, Ltd. has their corporate headquarters in Zhaoyuan City, Shandong Province, People's Republic of China.

The Company currently produces approximately 1,500,000 tons of Portland cement each year from two facilities in Hainan and one facility in Shandong. They expect their output will increase by 1,000,000 tons to a total of 2,500,000 tons when the new Zhaoyuan (Shandong) plant and upgrades complete. China Shuangji Cement, Ltd. will have four plants, once the new Zhaoyuan plant is operational.

On August 23, 2010, China Shuangji Cement, Ltd. announced their financial results for the second quarter ended June 30, 2010. Highlights include total revenue increasing 11.5 percent to $15.3 million from $13.7 million a year ago. Gross profit increased 14.0 percent to $2.4 million from $2.1 million a year ago. Gross margin increased to 15.8 percent from 15.4 percent in the same period last year.

Operating expenses were $715,596, up from $544,290 in the same period last year. Operating income rose 7.9 percent to $1.7 million from $1.6 million a year ago. Net income rose to $1.14 million compared to $1.13 million a year ago, an increase of $8,801.

“We are very excited about our prospects for the remainder of 2010 and beyond as China’s economy continues to expand,” said Mr. Wenji Song, Chairman and President of China Shuangji Cement, Ltd. “We see significant growth in construction and infrastructure projects in the fast growing areas where we operate, Shandong and Hainan provinces. This is supported by the government’s $586 billion stimulus package that calls for substantial investments in cement intensive projects for many years to come and the closure of outdated cement facilities. Going forward, we are excited about our prospects and have positioned ourselves to take advantage of these conditions as we complete equipment installation our new 1,000,000 metric ton cement plant and get ready to bring this facility online. We believe that our expected 66% increase in production capacity should translate into a commensurate increase in our sales and profits."

China Shuangji Cement, Ltd. (CSGJ) closed Friday’s trading session at $0.35, up 0.03%, on 238,128 volume with 56 trades. The stock’s average daily volume over the past 60 days is 23,746 with a 52-week low/high of $0.33/$1.94.

Tactical Air Defense Services Inc. (TADF)

OTC Picks reported recently on Tactical Air Defense Services Inc. (TADF), and we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Tactical Air Defense Services Inc. is an Aerospace/Defense Services contractor. The Company offers air-combat training, aerial refueling, aircraft maintenance training, disaster relief, and other Aerospace/Defense services to the United States and Foreign militaries and agencies. Tactical Air Defense Services Inc. trades on the OTC Bulletin Board. The Company has their headquarters in Carson City, Nevada.

Tactical Air Defense Services Inc. (TAD) consists of experienced military and aviation personnel who operate the Company's specialty aerial support services business. TADS have established itself as a leader in the rapidly growing industry of government outsourcing of aerospace/defense services to the private sector. Founded in 2001, TADS acquired the assets of AeroGroup, Incorporated in 2006.

They are the first private-sector defense contractor to receive certification and clearance from the U.S. government to provide these services. The Company has access to U.S. military aircraft such as F-16 and F-5 fighter aircraft. They also have access to Russian military aircrafts such as ILyushin IL-78 and IL-76 Super-Tankers, Mig-17 fighter aircraft, and Sukhoi SU-27 fighter aircraft. In addition, they have highly experienced military pilots, proprietary training and maintenance protocols.

From March 2008 through January 2009 TADS provided F-16 pilot training to the Belgian Air Force at the Kleine-Brogel Air Base in Belgium. This was via a contract awarded through U.S. Air Force – Air Education and Training Command (AETC).

In July 2009 TADS was awarded a commercial contract to deploy their ILyushin IL-78 Super-Tanker aircraft to the Middle East. This was to provide Air-to-Air Refueling research and development services.

In May of this year, Tactical Air Defense Services, Inc. announced that the Company received approval for membership in the U.S.-Ukraine Business Council (USUBC). Based in Washington, DC, the U.S.-Ukraine Business Council's membership includes large, well-known companies, as well as smaller private companies. Their interest is in fostering a stronger commercial relationship between the United States and Ukraine.

Tactical Air Defense Services Inc. (TADF) closed Friday’s trading session at $0.01, up 28.00%, on 18,123,658 volume with 178 trades. The stock’s average daily volume over the past 60 days is 6,455,722 with a 52-week low/high of $0.001/$0.05.

Sunvalley Solar, Inc. (SSOL)

Today, Bull Rally, Hot OTC, Cool Penny Stocks, Stock Rich, Penny Invest, and Stock Egg reported on Sunvalley Solar, Inc. (SSOL), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Los Angeles, California, Sunvalley Solar, Inc. is committed to reducing the world's carbon footprint from traditional energy sources. Their goal is to make renewable sources such as solar the nation's mainstream source of power. They are a leading solar system solution provider that offers comprehensive solar energy technology, system design, installation, equipments, and technical support.

Sunvalley Solar, Inc. provides their services for electrical contractors, builders, homeowners, businesses/commercial buildings, and government entities that assist them in lowering of utility bills, reducing environmental impacts, and increasing energy reliability and independence through solar energy.

The Company also offers turnkey solar system solutions. The turnkey systems offer clients complete solar installation kits. These include solar modules, inverters, advanced racking systems and engineering support for owners, builders and architectural firms. Sunvalley's customers range from small private residences to large commercial solar power users. They have designed and installed commercial solar power systems for large office buildings, manufacturing facilities, warehouses and many others.

Today, Sunvalley Solar, Inc. announced that they are now a publicly traded company. The Company trades on the OTC Bulletin Board. The Company was incorporated as "Western Ridge Minerals, Inc." on August 16, 2007 in the State of Nevada. On June 24, 2010, they entered into a Share Exchange Agreement with Sunvalley Solar, Inc., a private California corporation. They acquired all of the issued and outstanding common stock of Sunvalley. Shortly after consummation of the Share Exchange Agreement, they merged-in their wholly-owned subsidiary and changed their name to "Sunvalley Solar, Inc." They are now in the business of solar power technology, system design and integration.

The Company holds a C-46 Solar License from CBCL (California Board of Contractor License). Their proprietary technologies in solar installation provide their customers with a high quality, low cost and flexible solar power system solutions.

Sunvalley Solar, Inc. looks to continue their development as an end-to-end solar energy solution provider by providing system solution, post-sale service, customer technical support, solar system design and field installation.

Sunvalley Solar, Inc. (SSOL) closed Friday’s trading session at $0.04, up 27.42%, on 97,402,155 volume with 1,922 trades. The stock’s average daily volume over the past 60 days is 7,975 with a 52-week low/high of $0.0003/$0.051.

Flamel Technologies SA (FLML)

Motley Fool Hidden Gems reported earlier on Flamel Technologies SA (FLML), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Founded in 1990, Flamel Technologies, S.A. is a biopharmaceutical company that trades on the NASDAQ Global Market. The Company principally engages in the development of two unique polymer-based delivery technologies for medical applications. Flamel Technologies SA turns already-marketed or new drugs into more effective and safer medicines. The Company has assembled a strong team of experts in polymer science and biochemistry; including more than 35 Ph.D.s. Flamel Technologies SA has their corporate headquarters in Venissieux, France.

The Company's Micropump® is a controlled release and taste-masking technology for the oral administration of small molecule drugs. Flamel designed their Medusa® technology to deliver controlled-release formulations of proteins, peptides, and other large and small molecules. They are applying their Medusa platform to improve partners' already-marketed and novel biologics with respect to safety and efficacy, as well as with better pharmacokinetics. Medusa also offers important solutions to threshold issues such as aggregation and solubility.

Two world-renowned scientists help Flamel in their research and development work: Jean-Marie Lehn (Nobel Laureate in Chemistry in 1987) and Professor Christian Trepo, a world-renowned expert in liver diseases. Flamel Technologies owns a 103,900-square foot pharmaceutical production facility in Pessac, France. The facility provides Flamel with the capability to manufacture their "Good Manufacturing Practice" (cGMP)-grade pharmaceutical drugs for clinical trials utilizing their Micropump® or Medusa® technologies.

Flamel Technologies announced in November 2009 that Pfizer exercised their option to license Flamel's Medusa® technology. This technology is for the development of a controlled release formulation of an already-marketed therapeutic protein. Pfizer will pay all development costs of the program, including milestone payments and royalties on any commercial sales.

In December 2009, Flamel announced the initiation of a Phase 2a clinical trial of their Interferon alpha-2b XL (IFN-alpha-2b XL). It is based on Flamel's Medusa® platform for controlled release of biologics. IFN-alpha-2b XL is undergoing development as a controlled release of unmodified interferon alpha-2b for the treatment of chronic hepatitis C virus (HCV). This Phase 2a randomized study, known as ANRS HC 23 COAT-IFN (COnfirmation of Anti-viral activity and Tolerance of Interferon alpha-2b XL), is sponsored by the Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS).

The design of the Phase 2a study is to evaluate IFN-alpha-2b XL in combination with ribavirin in genotype-1 chronic hepatitis C patients who are either naive to treatment or previous non-responders to standard interferon therapy (PEGylated interferon plus ribavirin).

On July 28, 2010, Flamel Technologies announced three new partnership agreements and their financial results for the second quarter of 2010. Highlights include three new agreements with two pharmaceutical partners. Two agreements with a single partner involve the Micropump platform. A third agreement is for the development of a controlled release formulation involving a peptide and a protein intended to treat metabolic disease.

The Company also reported positive advances in their work with Pfizer and Merck Serono; as well as positive cash-flow at constant-currency rates.

Flamel Technologies SA (FLML) closed Friday’s trading session at $7.43, up 1.50%, on 12,693 volume with 41 trades. The stock’s average daily volume over the past 60 days is 55,193 with a 52-week low/high of $5.90/$9.92.

Novelos Therapeutics, Inc. (NVLT)

Stockpalooza, Penny Omega, Microcap Voice, Penny Stock DD, Stock Stars, The Street, The Dean, SmallCap Voice, Cool Penny Stocks, and HotOTC.com reported earlier on Novelos Therapeutics, Inc. (NVLT), and we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Novelos Therapeutics, Inc. is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis. Oxidized glutathione is a natural metabolite that is part of the glutathione pathway. This pathway is the primary determinant of intracellular redox (oxidation/reduction) potential. Its role in cell detoxification is well studied and understood. It has recognition as an important physiological regulator of redox-sensitive cell signaling pathways in multiple cell types. Novelos Therapeutics, Inc. trades on the OTCBB and they have their headquarters in Newton, Massachusetts.

The Company's lead products are believed to act, in part, through modification of cellular redox status. This leads to post-translational modification (glutathionylation) of critical regulatory proteins that mediate disease-relevant processes. These include tumor invasiveness, immune function, and blood cell formation.

Their NOV-002 has been administered to approximately 1,000 cancer patients in clinical trials and is in Phase 2 development for solid tumors in combination with chemotherapy. Novelos has a partnership with Mundipharma to develop and commercialize NOV-002 in Europe and Asia (excluding China).

Novelos has a second compound called NOV-205. It acts as a hepatoprotective agent with immunomodulating and anti-inflammatory properties. NOV-205, which has been administered to approximately 200 hepatitis patients in clinical trials, is in Phase 2 development for chronic hepatitis C non-responders.

Novelos Therapeutics, Inc.'s intellectual property includes six U.S., two European, and one Japanese issued patents. Novelos has filed more than 30 patent applications worldwide, with coverage including composition of matter, method of use, and manufacturing.

On July 12, 2010, Novelos Therapeutics, Inc. announced positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer. The trial is conducted by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. Alberto Montero, MD, Assistant Professor of Medicine at the Miller School and medical oncologist at Sylvester, is the Principal Investigator.

Novelos Therapeutics, Inc. (NVLT) closed Friday’s trading session at $0.06, up 22.45%, on 5,280,415 volume with 283 trades. The stock’s average daily volume over the past 60 days is 1,262,219 with a 52-week low/high of $0.0404/$3.05.

PolyMedix, Inc. (PYMX)

FeedBlitz and SmallCap Voice reported earlier on PolyMedix, Inc. (PYMX), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

PolyMedix, Inc. is an emerging biotechnology company that trades on the OTCBB. The Company is developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics - non-peptide small molecule drug candidates that mimic the activity of proteins. The Company has their headquarters in Radnor, Pennsylvania.

The Company's antibiotic compounds have a mechanism of action distinct from those of current antibiotic drugs. It is a mechanism whose intent is to make bacterial resistance unlikely to develop. The Company's goal is to develop these as rapidly acting antibiotics for serious systemic and local infections.

Their lead heptagonist compound, PMX-60056, is being developed to reverse the anticoagulant activity of both heparin and low molecular weight heparins. PolyMedix believes that PMX-60056 could potentially be a safer and easier to use anticoagulant reversing agent, with broader activity, than the currently approved therapy for reversing heparin.

PolyMedix’s lead antibiotic compound, PMX-30063, is a small molecule that mimics human host-defense proteins and has a mechanism of action distinct from those of current antibiotic drugs, a mechanism intended to make bacterial resistance unlikely to develop. PolyMedix plans to develop this compound for serious systemic Staphylococcal infections. This includes methicillin resistant Staphylococcus aureus (MRSA).

PMX-60056 heptagonist and PMX-30063 antibiotic are undergoing clinical testing. PolyMedix also plans to continue the development of their PolyCides™, polymeric formulations as antimicrobial biomaterials. These can be used as additives to paints, plastics, and textiles to create self-sterilizing products and surfaces.

On August 11, 2010, PolyMedix, Inc. announced that they have successfully completed a Phase 1B/2 dose-ranging clinical study with PMX-60056, a synthetic small-molecule designed to reverse heparin and low molecular weight heparin (LMWH) anticoagulants. The data from this study shows that PMX-60056 met the study endpoints regarding both the reversal of varying heparin levels, and allowing re-anticoagulation and re-reversal. The Company intends to use these data to support the development of a Phase 2 clinical trial in surgical patients.

PolyMedix, Inc. (PYMX) closed Friday's trading session at $0.95, up 1.06%, on 208,012 volume with 68 trades. The stock’s average daily volume over the past 60 days is 115,902 with a 52-week low/high of $0.64/$1.50.

Left Behind Games Inc. (LFBG)

Stockpalooza and FeedBlitz reported recently on Left Behind Games Inc. (LFBG), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Murrieta, California, Left Behind Games Inc., dba Inspired Media Entertainment, began in 2001 for the purpose of developing and publishing inspirational games. Their mission is to become the world's leading independent developer and publisher of quality interactive entertainment products that perpetuate positive values and appeal to mainstream and faith-based audiences. The Company trades on the OTC Bulletin Board.

Left Behind Games, Inc. is the only publicly-traded exclusive publisher of Christian video game software. The Company develops their video game products based on the Left Behind series of novels and products. Their primary product includes LEFT BEHIND: Eternal Forces, a real time strategy game played by one person or online by up to eight players.

The Company is a leading provider of quality Christian video games, which provide healthy alternatives to the gratuitously violent games in the marketplace. Products include the Charlie Church Mouse series of games for ages 2-8, Keys of the Kingdom for gamers of all ages, and the aforementioned Left Behind branded games for teens through adult ages.

They also offer Tribulation Forces, the sequel to the original game LEFT BEHIND: Eternal Forces, known as the most widely distributed Christian PC game in history. The Company's LEFT BEHIND branded games are based upon the popular novel series by Tim LaHaye and Jerry Jenkins.

Left Behind Games Inc. sells their products via a direct-to-store distribution channel. They also sell their products through distributors to Christian booksellers associations and inspirational marketplaces. The Company markets their products in North America, Australia, Canada, Singapore, and South Africa.

Today, Left Behind Games Inc. announced that revenues for the current quarter will exceed revenues for their last fiscal year.

LB Games CEO Troy Lyndon says, "We continue to experience sizable orders this quarter and see 2010 as an important year in the growth of the Christian video games genre."

Left Behind Games Inc. currently has seven Christian PC game titles with plans to release 4 new games in late October. These include LEFT BEHIND 3: Rise of the Antichrist, Charlie Church Mouse 3D Bible Adventures, Praise Champion and King Solomon's Trivia Challenge.

Left Behind Games Inc. (LFBG) closed Friday’s trading session at $0.0013, up 30.00%, on 195,148,917 volume with 699 trades. The stock’s average daily volume over the past 60 days is 7,588,425 with a 52-week low/high of $0.001/$0.0667.

The QualityStocks Company Corner

eDOORWAYS Corporation (EDWY)

The QualityStocks Daily Newsletter would like to spotlight eDOORWAYS Corporation (EDWY) Today eDoorways Corporation closed trading at $0.0025, for no change, on 938,600 volume with 11 trades. The stock’s average daily volume over the past 60 days is 3,202,543 with a 52-week low/high of $0.0011/$0.16.

eDOORWAYS Corp. (EDWY) is committed to solving lifestyle problems for consumers while driving traffic to suppliers and service providers who offer innovative merchandise and solutions. The company has the potential to completely change the future landscape of business by offering a unique and comprehensive service that saves consumers valuable time and money. By uniting a consumer with the larger global consumer community, retailers, and manufacturers in an effective new way, eDOORWAYS promotes “dynamic” commerce, as opposed to the static model currently in existence.

The Company plans to capitalize on several emerging new trends. These newly created opportunities include: the large success of Web 2.0 Internet community service offerings such as MySpace, the movement towards niche marketing and targeted advertising, the introduction of new technologies that enable instantaneous, online presentation of information, and the rising consumer preference for using the Internet to gain information before making purchasing decisions.

eDOORWAYS plans to introduce local services using a city-by-city strategy that will minimize capital requirements, reduce staffing requirements, and optimize generated revenues. Ten major cities are targeted for launch in the first year. Advertising, PR campaigns and viral word-of-mouth will be used to give a public presentation to experts as well as educate the market.

The key benefits offered to consumers include a higher level of engagement with vendors, trusted information from other consumers, and superior customer service. Revenues will be generated through advertising placement fees, premium services, preferential placement fees, and a percentage of sales transactions. eDOORWAYS' progressive vision and professional management team makes it an attractive investment opportunity. Disclaimer

eDOORWAYS Corporation Blog

eDOORWAYS Corporation News:

eDoorways Announces Launch of Virtual Martial Arts Competition PowerChannel

In A New Audio Interview at SmallCapVoice.com, Dr. Ramiro Jordan Discusses the New Technology from eDoorways Corporation

eDoorways Files Form 15, Focuses on Securing Additional Revenue Opportunities

Simulated Environment Concepts, Inc. (SMEV)

The QualityStocks Daily Newsletter would like to spotlight Simulated Environment Concepts, Inc. (SMEV). Today, Simulated Environment Concepts, Inc. closed trading at $0.02, up 39.44%, on 299,125 volume with 17 trades. The stock’s average daily volume over the past 60 days is 179,729 with a 52-week low/high of $0.001/$0.07.

Simulated Environment Concepts, Inc. (SMEV) is focused on manufacturing and distributing their patented SpaCapsule® as well as continued innovation in the areas of anti-aging, cosmetics, relaxation, cellulite reduction, and weight loss. Finding use in numerous environments such as relaxation centers, golf clubs, ski lounges, gyms, and health clubs, the SpaCapsule® provides next generation de-stressing and relaxation.

The company’s founders, Dr. Ella Frenkel and Dr. Ilya Spivak, initially capitalized Simulated Environment Concepts Inc. with several million dollars of their own money. With this initial investment, the company worked on, and succeeded in developing, the sleek and stylish looking pressurized dry water massage relaxation station.

SpaCapsule® is a full body massage, aromatherapy, audio and video entertainment system. The capsules are fused with advanced modern technology and healing methods of aromatherapy and audiovisual relaxation techniques, incorporating proprietary water-jet and pressure-jet technology that requires no on-site plumbing. Weighing approximately 500 lbs, the capsule only requires standard electric service.

Simulated Environment Concepts, Inc. (SMEV) anticipates progressive and consistent growth over the next six years. With individuals spending billions of dollars on de-stressing, weight loss, anti aging, cosmetics, massage and physical rehabilitations, the company is in a position to experience explosive growth from current levels. Disclaimer

Simulated Environment Concepts, Inc. Blog

Simulated Environment Concepts, Inc. News:

Ireland's Life and Fitness Magazine Profiles Simulated Environment Concepts' Flagship

Simulated Environment Concepts and UK Partner Aspire Consulting Expand Virbralife Fitness Program With Twelve SpaCapsule Units

Simulated Environment Concepts Attains Pink Sheets Current Information Status

National Automation Services, Inc. (NASV) 

The QualityStocks Daily Newsletter would like to spotlight National Automation Services, Inc. (NASV). Today, National Automation Services, Inc. closed trading at $0.07, for no change, on 4,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 17,271 with a 52-week low/high of $0.04/$0.158.

National Automation Services, Inc. (NASV) is a public holding company focused on designing, engineering, installing and maintaining automated control systems for such business applications as waste water treatment, water treatment, airport security, bottling plants, power plants, metals, mining, breweries, food processing, tire making, textiles, plastics and nearly all production activities.  

Dominant players in the $500 Billion national and international automation controls market include Siemens, Honeywell, Fisher Controls, Johnson Controls and others. In addition to the multi-nationals, it has been estimated that there could be as many as 300 local and regional firms providing automation control services. In general, these companies have an edge on the larger behemoths because they can better respond to the needs of local business and municipalities.  

Unfortunately, for these smaller companies, they compete in a limited market space, have stunted growth prospects and have no way of monetizing their asset value. NAS aims to capitalize on this condition by acquiring and integrating the strongest local and regional players into a new organization that would allow for the synergies and efficiencies of a national company while keeping the competitive advantages of decentralized management and service.  

Of the 300 local and regional automation companies, 42 meet the company’s acquisition criteria; 11 of which have been targeted for acquisition over the next two years. NAS projects year-end 2010 revenues of more than $47 Million and year-end 2011 revenues of over $140 Million predicated on meeting its targeted acquisition schedule. With a solid business plan in place, NAS has a firm foundation to generate strong cash flow and increase shareholder value over the long-term. Disclaimer

National Automotion Services, Inc. Blog

National Automation Services, Inc. News:

National Automation Services, Inc. Announces Its S-1 Registration Filing

National Automation Services, Inc. Operations and Investor Update

National Automation Services, Inc. Exhibiting New Product Offerings

Uranium Energy Corp. (UEC)

The QualityStocks Daily Newsletter would like to spotlight Uranium Energy Corp. (UEC) Today, Uranium Energy Corp. closed trading at $2.65, down 0.38%, on 106,519 volume with 313 trades. The stock’s average daily volume over the past 60 days is 345,625 with a 52-week low/high of $2.11/$4.16.

Uranium Energy Corp. (UEC) is a U.S.-based exploration and development company focused on near-term uranium production in the U.S. The company’s operations are managed by professionals who have earned a reputable profile through many decades of hands-on experience in the key facets of uranium exploration, development and mining.

Uranium Energy controls one of the largest databases of historic uranium exploration and development in the nation. Using this knowledge base, the company has acquired and is advancing exploration properties of merit throughout the southwestern U.S., a region known as being the most concentrated area for uranium mining in the United States.

The Company’s fully licensed and permitted Hobson processing facility is central to all of its projects in South Texas. Well financed to execute on its key programs, Uranium Energy's Palangana is-situ recovery project is fully permitted, and its Goliad in-situ recovery project is in the final stages of mine permitting for production.

The company’s strategy of acquiring exploration databases and leveraging those databases to generate acquisition targets has proven to be effective thus far. With plans to continue aggressively pursuing this strategy, Uranium Energy Corp is well positioned to capitalize on the world’s first significant alternative energy boom. Disclaimer

Uranium Energy Corp. Blog

Uranium Energy Corp. News:

Uranium Energy Corp Completes Phase One of Wellfield Development at Palangana in South Texas

Uranium Energy Corp Issues Mid-Year Shareholder Report

Uranium Energy Corp Announces Results of AGM

Simulated Environment Concepts (SMEV) Accessorizes

Considering that so much has been written about SpaCapsule®, the world’s most advanced water massage and personal relaxation system, a product of Simulated Environment Concepts Inc., it’s surprising that more hasn’t been said about the system’s accessories. The currency acceptor, for example, is what allows the system to take virtually any type of currency, a critical factor in the rapid globalization of SpaCapsule.

• Currency Acceptor – For a self-service environment, or when strict accounting control is required, SpaCapsule can be built with a Currency or Token Acceptor. These units become totally integrated into the software and hardware of the system. Because SpaCapsule is used around the world, the Currency Acceptor can be programmed to accept practically any local currency or token.

• Multi-Language Support – There are over 6,000 known languages spoken or written around the world. SEC has committed itself to providing a quality product to any country, accommodating local users in their native language. SpaCapsule is available with GUI (Graphic Users’ Interface) in any language, with no limit. The service is complimentary to all customers.

• Aromatherapy Supplies – Aromatherapy is considered one of the most evocative effects available with SpaCapsule, directly influencing emotions and the ability of the system to promote such total relaxation, through triggering of the brain’s limbic system. However, it requires the highest quality essential oils, which the company makes available to all buyers.

• Chiller System – For extreme environments, or when medically necessary to operate SpaCapsule at precise temperatures, SpaCapsule offers a line of water chillers. The chiller units provide superior cooling capacity to comparable units, and include options to allow optimization of chiller performance based on specific requirements.

• T-Max Compatibility – SpaCapsule is 100% T-Max Compatible, protecting the client’s investment by preventing any unwarranted sessions slipping by. (The company is the first and only Relaxation Equipment Manufacturer on the market providing this 100% compatibility.)

• Paper Supplies – Manufactured exclusively for SpaCapsule, these disposable face cushion papers combine an ultra softness of fabric with no-wash convenience. The special biodegradable weave gives users an exclusive cushion feeling that won’t irritate the skin, while keeping the face-cushion free from makeup and facial oils. It’s another important feature allowing clients to better maintain the system.

eDoorways Corp. (EDWY) Brand Strengthens in Depreciating Economic Environment

The eDoorways brand continues to pick up steam in spite of the struggling international markets. “America has gone through fundamental changes that have affected us all throughout the past few years,” stated Gary Kimmons, CEO of eDoorways International Corporation, in a press release today. “Fundamental structural change can be disconcerting because the events associated with it are often experienced as ‘random’ and ‘uncertain’.”

“It’s our perception that the changes we’re experiencing do bring challenges, but there are also significant opportunities,” Kimmons continued. These opportunities can be found in the areas of education, technology, sports, business expansion and charitable services.
eDoorways has always been focused on helping people find real solutions to their everyday problems using a “town square” platform to connect buyers with qualified sellers and service providers. However, management has found that there is much more eDoorways’ brand and business model can offer to the continually changing world.

Acknowledging their platform’s unique strengths, and the possibility of new and even greater opportunities, eDoorways created the eDoorways service offering and brand with both flexibility and extensibility in mind. The design enables robust organic growth that accommodates multiple vertical service offerings.

With continuous addition of new PowerChannels and consumers searching for answers, eDoorways has the capability of becoming a crucial part of the web, connecting businesses to consumers all over the world.

Cherokee Inc. (CHKE) Reports Second Quarter Financial Results

Cherokee Inc. reported a decline in sales and net income on a year over year basis in the second quarter of 2010, which ended 7/31/2010.

Cherokee Inc. had royalty sales of $7.5 million in the second quarter of 2010, compared to sales of $8.1 million in the same quarter of 2009. Cherokee Inc. reported net income of $2.5 million, or $0.28 per diluted share, compared to net income of $2.9 million, or $0.32 per diluted share, in the corresponding quarter of 2009.

The management of Cherokee Inc. said the decline in royalty sales was due to unfavorable exchange rates and lower international royalties. Royalties from U.S. based accounts increased during the quarter, but failed to make up for the impact of the previous two items.

Cherokee Inc. paid a dividend of $0.38 per share in the second quarter of 2010, and ended the quarter with cash and cash equivalents of $7.3 million. The company has no long term or short-term debt.

Cherokee Inc. owns several different brands, which the company licenses out to third parties for use on its products. These products include apparel, footwear, home furnishings, recreational items and accessories. The company’s brands include Cherokee, Sideout and Carole Little.

Comforce International, Inc. (CFRI) Announces Multi-Year Extension to Partnership with Bayer

Comforce International Inc. has developed an innovative composite flooring system, EKO-FLOR, engineered to replace the outmoded hardwood flooring employed by the transportation industry. The company is targeting its initial sales efforts on the container and trailer industries.

The company announced today that it has extended its strategic partnership with Bayer Material Science LLC to March 31, 2014. Bayer Material Science is one of the leading global polymer manufacturers and is a division of the German company Bayer AG – a recognized leader in health care, nutrition and the development of advanced materials.

The objective of the partnership is to leverage the two companies’ respective strengths as they work toward the successful commercialization of EKO-FLOR. Since February 2009, when the partnership was first established, Comforce and Bayer have developed efficient production processes and best practices in order to transition the company’s single-line development center into a scalable multi-line operation.

Comforce will continue to receive from Bayer key support in the areas of advanced design and material analysis, technical expertise, and a global material supply chain consistent with the projected volume requirements of EKO-FLOR. The two companies hope to transform the future of transportation design and engineering with EKO-FLOR. For further information on Comforce International, please visit the company’s website at www.comforceintl.com.


Sponsors of the Day


The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) Micro Identification Technologies (MIT): Independent Testing, Manufacturing, Sales and Financing Goals Converge



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336